PRAC meeting highlights 28 November - 1 December 2022

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

The current PRAC highlights from the November-December 2022 meeting describes the recommendation to withdrawal medicines containing pholcodine, and confirms regular COVID-19 vaccines safety updates will cease.